Enhanced expression of podoplanin in ameloblastomas

Journal of Oral Pathology and Medicine

Volumn 39, Issue 1, 2010, Pages 103-109

  González Alva, Patricia ^a,b   Tanaka, Akio ^c   Oku, Yuka ^c   Miyazaki, Yuji ^b   Okamoto, Eri ^c   Fujinami, Masahiro ^b   Yoshida, Noriaki ^b   Kikuchi, Kentaro ^b   Ide, Fumio ^b   Sakashita, Hideaki ^c   Kusama, Kaoru ^b  

^a Division of Pathology ^*  (Japan)

^b Department of Diagnostic and Therapeutic Sciences   (Japan)

^c MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Ameloblastoma; E cadherin; Immunohistochemistry; Podoplanin; Vimentin

Indexed keywords

PODOPLANIN; UVOMORULIN; VIMENTIN;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ARTICLE; CELL MEMBRANE; CELL TRANSFORMATION; CHILD; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 76249132038     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00818.x     Document Type: Article

References (30)

1. Thesleff I. Epithelial-mesenchymal signalling regulating tooth morphogenesis. J Cell Sci 2003 116 : 1647 1648.
2. Philipsen HP, Reichart PA, Slootweg PJ, et al. Odontogenic tumours. In : Barnes L, Evenson JW, Reichart PA, Sidransky D, eds. WHO classification of tumours. Pathology and genetics. Head and neck tumours. Lyon : IARC Press, 2005 283 327.
3. Kumamoto H. Molecular pathology of odontogenic tumors. J Oral Pathol Med 2006 35 : 65 74.
4. Heikinheimo K, Jee KJ, Aalto Y, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 2002 81 : 525 530.
5. Malliri A, Symons M, Hennigan RF, et al. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 1998 143 : 1087 1099.
6. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer 2007 96 : 1 5.
7. Martín-Villar E, Scholl FG, Gamallo C, et al. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 2005 113 : 899 910.
8. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007 39 : 305 318.
9. Mandal M, Myers JN, Lippman SM, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008 112 : 2088 2100.
10. Wells WA. Movement in Colorado: the Keystone Symposium on Cell Migration and Invasion Breckenridge, CO: January 18-23, 2003. J Cell Biol 2003 160 : 985 988.
11. Sawa Y, Iwasawa K, Ishikawa H. Expression of podoplanin in the mouse tooth germ and apical bud cells. Acta Histochem Cytochem 2008 41 : 121 126.
12. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 2008 26 : 354 360.
13. Yuan P, Temam S, El-Naggar A, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006 107 : 563 569.
14. Kono T, Shimoda M, Takahashi M, et al. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody. Int J Oncol 2007 31 : 501 508.
15. Atsumi N, Ishii G, Kojima M, et al. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem Byophys Res Commun 2008 373 : 36 41.
16. Raica M, Cimpean AM, Ribatti D. The role of podoplanin in tumor progression and metastasis. Anticancer Res 2008 28 : 2997 3006.
17. Wicki A, Lehembre F, Wick N, et al. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006 9 : 261 272.
18. Oku Y, Tanaka A, González-Alva P, et al. Podoplanin expression in human pleomorphic adenomas. In : Varma AK, Qiu WL, Zhang CP, Zhang ZY, eds. Oral oncology, Vol. 12. Shanghai : Ocean Papers & Printers, 2008 251 253.
19. King RE, Altini M, Shear M. Basal cell extensions in human oral mucosa. J Oral Pathol 1979 8 : 140 146.
20. Miyazaki Y, Okamoto E, González-Alva P, et al. The significance of podoplanin expression in human inflamed gingiva. J Oral Sci 2009 51 : 283 287.
21. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2002 83 : 337 376.
22. Ito T, Ishii G, Nagai K, et al. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies. Lung Cancer 2009 63 : 418 424.
23. Heikinheimo K, Happonen RP, Miettinen PJ, Ritvos O. Transforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors. J Clin Invest 1993 91 : 1019 1027.
24. Kumamoto H, Yoshida M, Ooya K. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors. J Oral Pathol Med 2002 31 : 539 548.
25. Kumamoto H, Ooya K. Expression of E-cadherin and alpha-catenin in epithelial odontogenic tumors: an immunohistochemical study. J Oral Pathol Med 1999 28 : 152 157.
26. Martín-Villar E, Megías D, Castel S, et al. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 2006 119 : 4541 4553.
27. Kumamoto H, Yamauchi K, Yoshida M, Ooya K. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 2003 32 : 114 120.
28. Wang A, Zhang B, Huang H, et al. Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro. BMC Cancer 2008 8 : 182.
29. Geho DH, Bandle RW, Clair T, Liotta LA. Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda) 2005 20 : 1994 1200.
30. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005 166 : 913 921.